文献速递血栓与止血

无创检测血友病携带者孕妇血浆中F8 int22h相关倒位及序列变异

Noninvasive detection of F8 int22h-related inversions and sequence variants in maternal plasma of hemophilia carriers.
PubMed 文献 · Blood · 2017-05-10

研究采用微滴数字PCR(ddPCR)和靶向大规模平行测序(MPS)分析孕妇血浆DNA,以无创判定血友病风险胎儿的突变状态。ddPCR在8至42周孕期的15例高危妊娠中正确判定胎儿血友病状态,3例未分类但无误判;靶向MPS通过捕获跨越F8基因的7.6-Mb区域,在3个血友病家系中正确诊断涉及int22h相关倒位的胎儿突变状态。数据提示靶向MPS可用于探查母源遗传的F8 int22h相关倒位,而ddPCR是识别孕妇血浆中F8和F9序列变异的可负担方法。

要点

  • ddPCR在15例8至42周高危妊娠中正确判定胎儿血友病状态,3例未分类,无误判。
  • 靶向MPS捕获跨越F8基因的7.6-Mb区域,在3个血友病家系中正确诊断胎儿突变状态。
  • 靶向MPS可用于探查母源遗传的F8 int22h相关倒位,ddPCR是识别F8和F9序列变异的可负担方法。

核心结论

  • 数据提示应用靶向MPS探查母源遗传的F8 int22h相关倒位是可行的,而ddPCR是识别孕妇血浆中F8和F9序列变异的可负担方法。
  • 这些进展可能为血友病序列变异携带者的妊娠管理带来益处,尤其是与最严重临床表型相关的常见F8 int22h相关倒位。

研究设计与样本

  • 研究采用微滴数字PCR(ddPCR)和靶向大规模平行测序(MPS)分析孕妇血浆DNA,以无创判定血友病风险胎儿的突变状态。
  • 设计家系特异性ddPCR assay检测散布于F8和F9基因的致病序列变异。
  • 对携带int22h相关倒位的携带者,采用基于单倍型的方法结合靶向MPS,通过捕获跨越F8基因的7.6-Mb区域推断胎儿基因型。

主要发现

  • ddPCR分析在8至42周孕期采集的样本中,正确判定15例高危妊娠的胎儿血友病状态。
  • 有3例未分类样本,但无误判。
  • 通过靶向MPS获得的涉及int22h相关倒位的F8基因区域详细胎儿单倍型图谱,使3个血友病家系的胎儿突变状态得到正确诊断。

局限性

  • ddPCR分析中有3例未分类样本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Direct detection of F8 and F9 sequence variants in maternal plasma of hemophilia carriers has been demonstrated by microfluidics digital PCR. Noninvasive prenatal assessment of the most clinically relevant group of sequence variants among patients with hemophilia, namely, those involving int22h-related inversions disrupting the F8 gene, poses additional challenges because of its molecular complexity. We investigated the use of droplet digital PCR (ddPCR) and targeted massively parallel sequencing (MPS) for maternal plasma DNA analysis to noninvasively determine fetal mutational status in pregnancies at risk for hemophilia. We designed family-specific ddPCR assays to detect causative sequence variants scattered across the F8 and F9 genes. A haplotype-based approach coupled with targeted MPS was applied to deduce fetal genotype by capturing a 7.6-Mb region spanning the F8 gene in carriers with int22h-related inversions. The ddPCR analysis correctly determined fetal hemophilia status in 15 at-risk pregnancies in samples obtained from 8 to 42 weeks of gestation. There were 3 unclassified samples, but no misclassification. Detailed fetal haplotype maps of the F8 gene region involving int22h-related inversions obtained through targeted MPS enabled correct diagnoses of fetal mutational status in 3 hemophilia families. Our data suggest it is feasible to apply targeted MPS to interrogate maternally inherited F8 int22h-related inversions, whereas ddPCR represents an affordable approach for the identification of F8 and F9 sequence variants in maternal plasma. These advancements may bring benefits for the pregnancy management for carriers of hemophilia sequence variants; in particular, the common F8 int22h-related inversions, associated with the most severe clinical phenotype.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Hudecova I, Jiang P, Davies J, et al. Noninvasive detection of F8 int22h-related inversions and sequence variants in maternal plasma of hemophilia carriers. Blood. 2017. PMID: 28490568. doi:10.1182/blood-2016-12-755017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。